Effectiveness and Predictors of Response to Somatostatin Analogues in Patients With Gastrointestinal Angiodysplasias
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Gastroenterology & Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis
Lancet Gastroenterol Hepatol 2021 Nov 01;6(11)922-932, LCMJ Goltstein, KV Grooteman, A Rocco, G Holleran, S Frago, PS Salgueiro, T Aparicio, G Scaglione, S Chetcuti Zammit, R Prados-Manzano, R Benamouzig, G Nardone, D McNamara, M Benallaoua, S Michopoulos, R Sidhu, W Kievit, JPH Drenth, EJM van GeenenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.